MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses
Authors
Keywords
H5N1, T cells, Influenza, Influenza viruses, Enzyme-linked immunoassays, Cytotoxic T cells, Antibodies, Immune response
Journal
PLoS One
Volume 9, Issue 2, Pages e88340
Publisher
Public Library of Science (PLoS)
Online
2014-02-12
DOI
10.1371/journal.pone.0088340
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toward a Universal Influenza Virus Vaccine: Prospects and Challenges
- (2013) Natalie Pica et al. Annual Review of Medicine
- Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine
- (2013) Caitlin E. Mullarkey et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunological assessment of influenza vaccines and immune correlates of protection
- (2013) Adrian Reber et al. Expert Review of Vaccines
- Antibody Correlates and Predictors of Immunity to Naturally Occurring Influenza in Humans and the Importance of Antibody to the Neuraminidase
- (2013) Robert B. Couch et al. JOURNAL OF INFECTIOUS DISEASES
- Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses
- (2013) Di Liu et al. LANCET
- Cellular immune correlates of protection against symptomatic pandemic influenza
- (2013) Saranya Sridhar et al. NATURE MEDICINE
- Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
- (2013) Rongbao Gao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus
- (2013) Alessandra Vitelli et al. PLoS One
- The prospects and challenges of universal vaccines for influenza
- (2013) Kanta Subbarao et al. TRENDS IN MICROBIOLOGY
- Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice
- (2013) Joseph N. Brewoo et al. VACCINE
- Immunity Against Heterosubtypic Influenza Virus Induced By Adenovirus And MVA Expressing Nucleoprotein And Matrix Protein-1
- (2013) Teresa Lambe et al. Scientific Reports
- Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge
- (2012) Masoumeh Tavassoti Kheiri et al. ANTIVIRAL RESEARCH
- A DNA vaccine expressing PB1 protein of influenza A virus protects mice against virus infection
- (2012) Ivan Košík et al. ARCHIVES OF VIROLOGY
- Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
- (2012) Patrick J. Lillie et al. CLINICAL INFECTIOUS DISEASES
- Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms
- (2012) K. Kai McKinstry et al. JOURNAL OF CLINICAL INVESTIGATION
- Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
- (2012) Tom M Wilkinson et al. NATURE MEDICINE
- Robust Immunity and Heterologous Protection against Influenza in Mice Elicited by a Novel Recombinant NP-M2e Fusion Protein Expressed in E. coli
- (2012) Wenling Wang et al. PLoS One
- Highly Conserved Protective Epitopes on Influenza B Viruses
- (2012) C. Dreyfus et al. SCIENCE
- A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate
- (2012) Walter Wodal et al. VACCINE
- Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination
- (2012) Céline Verheust et al. VACCINE
- Towards a universal vaccine for avian influenza: Protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus
- (2012) Amy C. Boyd et al. VACCINE
- Subcutaneous immunization with recombinant adenovirus expressing influenza A nucleoprotein protects mice against lethal viral challenge
- (2012) Anwar Hashem et al. Human Vaccines & Immunotherapeutics
- Prospecting the Influenza Hemagglutinin to Develop Universal Vaccines
- (2011) R. O. Donis et al. CLINICAL INFECTIOUS DISEASES
- Cytotoxic CD4 T Cells in Antiviral Immunity
- (2011) Nikki B. Marshall et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Contributions of Antinucleoprotein IgG to Heterosubtypic Immunity against Influenza Virus
- (2011) Mark W. LaMere et al. JOURNAL OF IMMUNOLOGY
- Hallmarks of CD4 T cell immunity against influenza
- (2011) K. K. McKinstry et al. JOURNAL OF INTERNAL MEDICINE
- Interplay between Modified Vaccinia Virus Ankara and Dendritic Cells: Phenotypic and Functional Maturation of Bystander Dendritic Cells
- (2011) M. F. Pascutti et al. JOURNAL OF VIROLOGY
- Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity
- (2011) Annett Hessel et al. PLoS One
- Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity
- (2011) Jae-Min Song et al. PLoS One
- Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever
- (2011) Birgit Schäfer et al. PLoS One
- Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza
- (2011) Byoung-Shik Shim et al. PLoS One
- A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
- (2011) D. Corti et al. SCIENCE
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
- (2011) D. C. Ekiert et al. SCIENCE
- The changing nature of avian influenza A virus (H5N1)
- (2011) Yohei Watanabe et al. TRENDS IN MICROBIOLOGY
- Selection of recombinant MVA by rescue of the essential D4R gene
- (2011) Patricia S Ricci et al. Virology Journal
- Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2010) R. J. Amato et al. CLINICAL CANCER RESEARCH
- Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
- (2010) T. K. Berthoud et al. CLINICAL INFECTIOUS DISEASES
- Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model
- (2010) J. H. C. M. Kreijtz et al. JOURNAL OF GENERAL VIROLOGY
- A Universal Influenza A Vaccine Based on Adenovirus Expressing Matrix-2 Ectodomain and Nucleoprotein Protects Mice From Lethal Challenge
- (2010) Dongming Zhou et al. MOLECULAR THERAPY
- A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations
- (2010) Annett Hessel et al. PLoS One
- Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses
- (2010) Graeme E. Price et al. PLoS One
- Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge
- (2010) G. Bommakanti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus
- (2010) Haiyan Chang et al. Virology Journal
- An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus
- (2010) Guangyu Zhao et al. Virology Journal
- An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses
- (2010) Guangyu Zhao et al. Virology Journal
- Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
- (2010) J. Steel et al. mBio
- Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara
- (2009) Guus F Rimmelzwaan et al. Expert Review of Vaccines
- Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments
- (2009) Michael Schotsaert et al. Expert Review of Vaccines
- The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+T cells
- (2009) Oliver Dienz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection
- (2009) J. Mayrhofer et al. JOURNAL OF VIROLOGY
- Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses
- (2009) J.H.C.M. Kreijtz et al. VACCINE
- Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses
- (2009) Graeme E. Price et al. VACCINE
- M2e-based universal influenza A vaccine
- (2009) Walter Fiers et al. VACCINE
- The Poxvirus Vectors MVA and NYVAC as Gene Delivery Systems for Vaccination Against Infectious Diseases and Cancer
- (2008) Carmen Gomez et al. CURRENT GENE THERAPY
- Recombinant Modified Vaccinia Virus Ankara Expressing the Hemagglutinin Gene Confers Protection against Homologous and Heterologous H5N1 Influenza Virus Infections in Macaques
- (2008) J. H. C. M. Kreijtz et al. JOURNAL OF INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now